David MD - Alimera Sciences Chief Specialist
| ALIMDelisted Stock | USD 5.54 0.01 0.18% |
Insider
David MD is Chief Specialist of Alimera Sciences
| Phone | 678 990 5740 |
| Web | https://alimerasciences.com |
Alimera Sciences Management Efficiency
Alimera Sciences' management efficiency ratios could be used to measure how well Alimera Sciences manages its routine affairs as well as how well it operates its assets and liabilities.Alimera Sciences currently holds 67.4 M in liabilities. Alimera Sciences has a current ratio of 1.27, suggesting that it is in a questionable position to pay out its financial obligations when due. Note, when we think about Alimera Sciences' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Claude Maraoui | Journey Medical Corp | 57 | |
| Xiaodong Pan | China SXT Pharmaceuticals | 46 | |
| Zorina Pitkin | Organogenesis Holdings | N/A | |
| Lori Gorski | Cyclo Therapeutics | N/A | |
| Mitchell MBA | Petros Pharmaceuticals | 60 | |
| Tyvin MD | Shuttle Pharmaceuticals | 76 | |
| Robert Weinstein | Petros Pharmaceuticals | 64 | |
| Albert Bolles | Lifecore Biomedical | 66 | |
| Patrick Bilbo | Organogenesis Holdings | 62 | |
| Michael Hoek | Shuttle Pharmaceuticals | 64 | |
| Sam Hsing | China Pharma Holdings | N/A | |
| Jeffrey Tate | Cyclo Therapeutics | 66 | |
| Ernest Galvan | Journey Medical Corp | 62 | |
| E Strattan | Cyclo Therapeutics | 78 | |
| Feng Zhou | China SXT Pharmaceuticals | 32 | |
| Brian Grow | Organogenesis Holdings | 48 | |
| George Fails | Cyclo Therapeutics | 79 | |
| Michael Starkweather | Shuttle Pharmaceuticals | 40 | |
| Keith Lavan | Petros Pharmaceuticals | 60 | |
| CSC MD | Shuttle Pharmaceuticals | 57 | |
| Scott Fine | Cyclo Therapeutics | 67 | |
Management Performance
| Return On Equity | -0.35 | |||
| Return On Asset | 0.0098 |
Alimera Sciences Leadership Team
Elected by the shareholders, the Alimera Sciences' board of directors comprises two types of representatives: Alimera Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alimera. The board's role is to monitor Alimera Sciences' management team and ensure that shareholders' interests are well served. Alimera Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alimera Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Visick, General VP | ||
| Philip Ashman, Sr. VP and European Managing Director | ||
| Jason Werner, Chief Officer | ||
| David Holland, Co-Founder and Sr. VP of Sales and Marketing | ||
| Todd Wood, President Operations | ||
| Richard Eiswirth, Pres and CFO | ||
| Charles Myers, NonEx Consultant | ||
| David MD, Chief Specialist | ||
| Elliot CPA, CFO Treasurer |
Alimera Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alimera Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.35 | |||
| Return On Asset | 0.0098 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 360.44 M | |||
| Shares Outstanding | 54.38 M | |||
| Shares Owned By Insiders | 5.34 % | |||
| Shares Owned By Institutions | 86.54 % | |||
| Number Of Shares Shorted | 578.49 K | |||
| Price To Earning | 1.65 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |